These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 26477029

  • 1. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
    Botsikas D, Kalovidouri A, Becker M, Copercini M, Djema DA, Bodmer A, Monnier S, Becker CD, Montet X, Delattre BM, Ratib O, Garibotto V, Tabouret-Viaud C.
    Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
    [Abstract] [Full Text] [Related]

  • 2. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Botsikas D, Bagetakos I, Picarra M, Da Cunha Afonso Barisits AC, Boudabbous S, Montet X, Lam GT, Mainta I, Kalovidouri A, Becker M.
    Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.
    Nuklearmedizin; 2014 Apr; 53(3):89-94. PubMed ID: 24220324
    [Abstract] [Full Text] [Related]

  • 4. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
    Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B, Forsting M, Ruhlmann V, Umutlu L.
    Eur J Radiol; 2017 Apr; 89():14-19. PubMed ID: 28267530
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
    Taneja S, Jena A, Goel R, Sarin R, Kaul S.
    Eur J Radiol; 2014 Dec; 83(12):2231-2239. PubMed ID: 25282709
    [Abstract] [Full Text] [Related]

  • 7. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EA, Kimmig KR, Forsting M, Bockisch A, Antoch G.
    J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
    [Abstract] [Full Text] [Related]

  • 8. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW, Everaert H, Makkat S, Sacré R, Lamote J, Bourgain C.
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [Abstract] [Full Text] [Related]

  • 9. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM, Grueneisen J, Stebner V, Klode J, Stoffels I, Umutlu L, Schadendorf D, Heusch P, Antoch G, Pöppel TD.
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [Abstract] [Full Text] [Related]

  • 10. Comparison of 18F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix.
    Sarabhai T, Schaarschmidt BM, Wetter A, Kirchner J, Aktas B, Forsting M, Ruhlmann V, Herrmann K, Umutlu L, Grueneisen J.
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):67-76. PubMed ID: 28840302
    [Abstract] [Full Text] [Related]

  • 11. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
    van Nijnatten TJA, Goorts B, Vöö S, de Boer M, Kooreman LFS, Heuts EM, Wildberger JE, Mottaghy FM, Lobbes MBI, Smidt ML.
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
    [Abstract] [Full Text] [Related]

  • 12. FDG PET/MR for lymph node staging in head and neck cancer.
    Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Kitzler HH, Maus J, Schramm G, Popp M, Laniado M, Kotzerke J, van den Hoff J.
    Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792
    [Abstract] [Full Text] [Related]

  • 13. Impact of 18F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithms.
    Kirchner J, Martin O, Umutlu L, Herrmann K, Bittner AK, Hoffmann O, Mohrmann S, Gauler T, Theurer S, Antke C, Esposito I, Kinner S, Schaarschmidt BM, Kowall B, Lütke-Brintrup D, Stang A, Becker AS, Antoch G, Buchbender C.
    Eur J Radiol; 2020 Jul; 128():108975. PubMed ID: 32371185
    [Abstract] [Full Text] [Related]

  • 14. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
    Lee DH, Kim SH, Joo I, Hur BY, Han JK.
    Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
    [Abstract] [Full Text] [Related]

  • 15. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 16. Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
    Morawitz J, Bruckmann NM, Dietzel F, Ullrich T, Bittner AK, Hoffmann O, Ruckhäberle E, Mohrmann S, Häberle L, Ingenwerth M, Abrar DB, Sawicki LM, Breuckmann K, Fendler WP, Herrmann K, Buchbender C, Antoch G, Umutlu L, Kirchner J.
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):992-1001. PubMed ID: 34476552
    [Abstract] [Full Text] [Related]

  • 17. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
    Cermik TF, Mavi A, Basu S, Alavi A.
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):475-83. PubMed ID: 17957366
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM, Grueneisen J, Schaarschmidt BM, Buchbender C, Nagarajah J, Umutlu L, Antoch G, Kinner S.
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [Abstract] [Full Text] [Related]

  • 19. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 20. FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR.
    Platzek I, Beuthien-Baumann B, Ordemann R, Maus J, Schramm G, Kitzler HH, Laniado M, Kotzerke J, van den Hoff J.
    Acad Radiol; 2014 Oct; 21(10):1314-9. PubMed ID: 25086953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.